Principal Investigator
Hadar Lev-Tov
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240719
Clinical Trial Summary
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of subcutaneous sonelokimab in adult participants with moderate to severe hidradenitis suppurativa
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other